SOURCE: Acclaris

Acclaris

June 18, 2015 11:00 ET

Acclaris CEO Dean Mason to Speak at The Institute for HealthCare Consumerism's Sixth Annual IHC FORUM & Expo

Mason to Participate in Expert Panel on Defined Contribution and Private Exchanges

TAMPA, FL--(Marketwired - Jun 18, 2015) -  Acclaris, a leading Software as a Service (SaaS) technology and services provider for consumer-directed accounts, today announced that CEO Dean Mason will be participating in an expert panel at The Institute for HealthCare Consumerism's Sixth Annual IHC FORUM & Expo, held June 23-25 in Atlanta, Georgia.

On Thursday, June 25 at 10:30 a.m. ET, Mason will join a panel discussion on defined contribution and private exchanges. He will share his expert insights and experiences, as well as his take on what to expect in 2016. Additionally, Acclaris will be exhibiting in Booth #217.

Moderated by Doug Field, CEO of The Institute for HealthCare Consumerism, "Session 407: Leading Experts on Private Exchanges Discuss the Models, the Current Experiences and What is Coming for 2016, Including Updates on Public Exchanges" will explore how private exchanges epitomize consumer-driven healthcare by empowering consumers to make important decisions regarding their health coverage. Panelists will examine how private and public exchanges have fared and why. They will also share their perspectives on the future, including how the industry can reap their potential benefits.

"The growing focus on consumer engagement in healthcare may be the most significant transformation the industry will ever experience. To succeed in this new era, employers and health plans need to understand how to actively engage consumers," noted Mason. "The IHC FORUM & Expo is one of the few industry events entirely devoted to exploring healthcare consumerism. I look forward to delving into how exchanges and defined-contribution approaches fit into the shift to consumerism and offering my thoughts on consumer engagement strategies."

ABOUT ACCLARIS

Acclaris provides the services and technology that health plans, benefit consultants and financial institutions rely on to deliver health care and reimbursement accounts to a growing market. Acclaris stands out from the competition for its operational efficiency, configurable (SaaS) technology and responsive service team. Partnering with Acclaris, clients of all sizes are able to deliver a range of innovative account options and an exceptional consumer experience. Acclaris was recently acquired by Towers Watson (NASDAQ: TW), and will become the Consumer Directed Accounts line of business within Towers Watson's Exchange Solutions segment. Learn more at acclaris.com.

ABOUT TOWERS WATSON

Towers Watson (NASDAQ: TW) is a leading global professional services company that helps organizations improve performance through effective people, risk and financial management. With 15,000 associates around the world, the company offers consulting, technology and solutions in the areas of benefits, talent management, rewards, and risk and capital management. Learn more at towerswatson.com.

Forward-Looking Statements

This document contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements and other forward-looking statements in this document by words such as "may," "will," "would," "expect," "anticipate," "believe," "estimate," "plan," "intend," "continue," or similar words, expressions or the negative of such terms or other comparable terminology. Such statements are based upon the current beliefs and expectations of Towers Watson's management, and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements.

The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: a decline in client demand (for example, resulting from the reduced use of defined benefit plans); the risk of a disclosure breach of company or client data; the risk of translation exposure impacting our results, arising from foreign currency exchange, and interest rate fluctuations and volatility; the ability to successfully make suitable acquisitions and divestitures; the risk that the acquisitions of Acclaris, Saville Consulting or other acquisitions are not profitable or successful, or are not otherwise successfully integrated; our ability to protect client data and our information systems; the risk that potential changes in federal and state health care regulations, or future interpretation of existing regulations, may have a material adverse impact on our business; the risk that our Exchange Solutions or OneExchange businesses fail to maintain good relationships with insurance carriers, become dependent upon a limited number of insurance carriers or fail to develop new insurance carrier relationships; the risk that changes and developments in the health insurance system in the United States could harm our business; our ability to respond to rapid technological changes; the ability to recruit and retain qualified employees and to retain client relationships; and the risk that a significant or prolonged economic downturn could have a material adverse effect on Towers Watson's business, financial condition and results of operations. Additional risks and factors are identified under "Risk Factors" in Towers Watson's most recent annual report on Form 10-K filed with the Securities and Exchange Commission.

You should not rely upon forward-looking statements as predictions of future events because these statements are based on assumptions that may not come true and are speculative by their nature. Towers Watson does not undertake an obligation to update any of the forward-looking information included in this document, whether as a result of new information, future events, changed expectations or otherwise.

Contact Information

  • Media Contact:
    Erica Camilo
    Connexa Communications for Acclaris
    Email Contact
    610.639.5644